OTCMKTS:REMI Remedent (REMI) Stock Price, News & Analysis $0.05 0.00 (0.00%) (As of 11/13/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsFinancialsSEC Filings About Remedent Stock (OTCMKTS:REMI) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Remedent alerts:Sign Up Key Stats Today's Range$0.05▼$0.0550-Day Range$0.05▼$0.0652-Week Range$0.00▼$0.15VolumeN/AAverage Volume2 shsMarket Capitalization$1 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewRemedent, Inc. researches, designs, develops, manufactures, and distributes oral care and cosmetic dentistry products in the United States and internationally. It primarily provides professional veneers and teeth whitening products for professional and over-the-counter use. The company also offers River8, a prefab veneer that enables the dentist to find the right combination of teeth for a patient with minor reshaping. In addition, it provides GlamSmile veneers, which are ultra-thin claddings attached to the front of the patient's teeth. Further, the company offers SmileMe Mirror, an integrated marketing concept for the dental practice that enables dentists to offer smile consultation in approximately 10 minutes; SmileSketch, a simulation software to make a sketch of what the patient could look like; and various Treatment Pages to explain the benefits of certain treatments, as well as Condor, an intra-oral 3D scanner. Additionally, it provides dental implant solutions and treatment concepts. The company sells its products through internal sales force and third party distributors. Remedent, Inc. was incorporated in 1986 and is headquartered in Ghent, Belgium.Read More… Trump’s Sending THIS Crypto Higher on Purpose (Ad)Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Receive REMI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Remedent and its competitors with MarketBeat's FREE daily newsletter. Email Address REMI Stock News HeadlinesEx-Chelsea striker looks like completely new person just one year after retirementAugust 28, 2024 | mirror.co.ukREMYY Rémy Cointreau SAApril 24, 2024 | seekingalpha.comIs Your 401(k) Safe? The Real Risk No One Sees ComingEvery day you wait, your savings are at greater risk. The government isn't slowing down, inflation isn't stopping, and the digital dollar is coming. You can protect yourself—but only if you act now. Don't wake up too late. Get your Digital Dollar Protection today and secure your retirement before the window closes.November 14, 2024 | Golden Crest (Ad)Peterson RemyFebruary 15, 2024 | health.usnews.comRemi Wolf Returns with New Single “Prescription,” Inspired by Phone Call with Boots Riley: StreamJune 2, 2023 | yahoo.comLove Island star Remi Lambert claims he was assaulted by one of Jacques O'Neill's friendsMarch 22, 2023 | mirror.co.ukWhere is Remi Adeleke and who is Chris Oliver from SAS: Who Dares Wins?January 25, 2023 | uk.news.yahoo.comRemedent, Inc. (REMI)August 22, 2022 | finance.yahoo.comSee More Headlines REMI Stock Analysis - Frequently Asked Questions How have REMI shares performed this year? Remedent's stock was trading at $0.0970 at the beginning of 2024. Since then, REMI shares have decreased by 48.5% and is now trading at $0.05. View the best growth stocks for 2024 here. How do I buy shares of Remedent? Shares of REMI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Remedent own? Based on aggregate information from My MarketBeat watchlists, some other companies that Remedent investors own include AbbVie (ABBV), CoStar Group (CSGP), Enterprise Products Partners (EPD), Kellanova (K), Kandi Technologies Group (KNDI), MKS Instruments (MKSI) and M&T Bank (MTB). Company Calendar Today11/14/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Dental equipment & supplies Sub-IndustryN/A Current SymbolOTCMKTS:REMI CUSIPN/A CIK1078037 Webwww.remedent.com Phone(329) 241-5880Fax329-241-5899Employees3Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-270,000.00 Net Margins-25.56% Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$990,000.00 Price / Sales1.01 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares20,000,000Free FloatN/AMarket Cap$1 million OptionableNot Optionable Beta-0.01 Social Links Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report This page (OTCMKTS:REMI) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersIs Your 401(k) Safe? The Real Risk No One Sees ComingEvery day you wait, your savings are at greater risk. The government isn't slowing down, inflation isn't stopp...Golden Crest | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | SponsoredTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Remedent, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Remedent With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.